26 January 2017 Application of the laser diode with central wavelength 975 nm for the therapy of neurofibroma and hemangiomas
Author Affiliations +
Abstract
This paper presents a newly developed dermatological laser (with a central wavelength 975 nm) for application in therapies requiring deep penetration of tissue, e.g., cutaneous (dermal) neurofibroma (von Recklinghausen disease) and hemangiomas. This laser can work either in pulses or continues wave mode. Laser radiation is transmitted toward the application region by optical fiber with a diameter of 0.6 mm. The compact design of the laser facilitates its transport and increases the comfort of use.
© 2017 Society of Photo-Optical Instrumentation Engineers (SPIE)
Jacek Szymańczyk, Mirosław Sawczak, Witold Cenian, Katarzyna Karpienko, Małgorzata Jędrzejewska-Szczerska, Adam Cenian, "Application of the laser diode with central wavelength 975 nm for the therapy of neurofibroma and hemangiomas," Journal of Biomedical Optics 22(1), 010502 (26 January 2017). https://doi.org/10.1117/1.JBO.22.1.010502 . Submission: Received: 8 September 2016; Accepted: 6 January 2017
Received: 8 September 2016; Accepted: 6 January 2017; Published: 26 January 2017
JOURNAL ARTICLE
4 PAGES


SHARE
Back to Top